Governance Transition FAQs

What governance transition is SASB undergoing? SASB is transitioning to a two-tiered governance model with separation of financial responsibilities from the standards-setting activities. In the new model, an entity called...
Published February 15, 2017 by Sasb
Read more

Despite Headline Risks, Disclosure on Drug Pricing Remains Limited for Pharmaceuticals Companies

How and why SASB is working towards enhanced disclosure on pricing strategies. In 2016, drug pricing emerged as a headline risk for the pharmaceuticals industry. Several cases demonstrated how pricing...
Published February 13, 2017 by Eric Kane
Read more

Moving from Provisional to Codified: An Update on the Consultation Period

SASB’s deep consultation process on the Provisional Standards and proposed updates is going “full speed ahead.” We invite corporate issuers and investors interested in participating to reach out to schedule...
Published February 6, 2017 by Sasb
Read more

A Letter from Jean Rogers, SASB’s CEO

Dear SASB Stakeholders, Four years ago, SASB embarked upon an ambitious task. We promised the markets that by March 2016 we would issue sustainability accounting standards for all major industries...
Published April 6, 2016 by Jill Richardson
Read more